Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2325 of 3546 entries
View as:

Safety Study of GSK Biologicals' Rotavirus Vaccine (Rotarix®) Administered to Children Aged <1 Year in the United States

Phase: N/A Priority: Normal
NCT ID: NCT00875641 Org: User:
Start: 04/20/09 End: 11/04/16 Due: 11/04/17

Use Of SB424323 With Aspirin In Non-Valvular Atrial Fibrillation In Patients At A Low Or Intermediate Risk For Stroke

Phase: N/A Priority: Normal
NCT ID: NCT00240643 Org: User:
Start: 11/30/05 End: 12/31/06 Due: 12/31/07

Japan PhI/II of GSK2118436 and GSK1120212 Combination in Subjects With BRAF V600E/K Mutation Positive Advanced Solid Tumors (Phase I Part) or Cutaneous Melanoma (Phase II Part)

Phase: N/A Priority: Normal
NCT ID: NCT01928940 Org: User:
Start: 08/15/13 End: 07/04/16 Due: 07/04/17

Letetresgene Autoleucel Engineered T Cells Alone and in Combination With Pembrolizumab in NY-ESO-1 Positive Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT03168438 Org: User:
Start: 08/18/17 End: 11/05/20 Due: 11/05/21

Trial to Evaluate the Safety and the Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in Healthy Children

Phase: N/A Priority: Normal
NCT ID: NCT01096056 Org: User:
Start: 04/05/10 End: 12/13/10 Due: 12/13/11

Epidemiological, Observational and Post Marketing Study of Rotarix™ in Children With Severe Gastroenteritis in Belgium

Phase: N/A Priority: Normal
NCT ID: NCT01339221 Org: User:
Start: 03/31/11 End: 06/30/12 Due: 06/30/13

A Study to Evaluate the Efficacy, Immunogenicity and Safety in a Sporozoite Challenge Model of a Fractional Booster Dose of GSK Biologicals' Candidate Malaria Vaccine Administered to Previously Vaccinated Healthy Malaria-naïve Adults

Phase: N/A Priority: Normal
NCT ID: NCT03824236 Org: User:
Start: 02/05/19 End: 09/26/19 Due: 09/26/20

Special Drug Use Investigation for VALTREX (Valaciclovir) (Pediatrics Chickenpox)

Phase: N/A Priority: Normal
NCT ID: NCT01390857 Org: User:
Start: 11/30/07 End: 05/31/10 Due: 05/31/11

A Phase 2 Study to Evaluate the Safety, Tolerability, and Immune Response of AFX3772 Vaccine in Healthy Infants

Phase: N/A Priority: Normal
NCT ID: NCT05412030 Org: User:
Start: 06/16/22 End: 07/23/26 Due: 07/23/27

A Single Dose Study to Assess the Regional Absorption and Bioavailability of 100mg GSK2190915A

Phase: N/A Priority: Normal
NCT ID: NCT01318980 Org: User:
Start: 09/30/10 End: 03/11/11 Due: 03/11/12

At What Time Therapeutic Plasma Concentrations of Paracetamol Are Achieved in Two Marketed Formulations

Phase: N/A Priority: Normal
NCT ID: NCT01551836 Org: User:
Start: 06/30/09 End: 06/30/09 Due: 06/30/10

A Efficacy Against Otitis Media in Children With 11 Valent Pneumococcal Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00119743 Org: User:
Start: 10/31/00 End: 06/30/04 Due: 06/30/05

An Open-Label Extension Study Of Lamotrigine In Subjects With Bipolar Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00360126 Org: User:
Start: 10/31/05 End: 02/28/07 Due: 02/28/08

Safety and Immunogenicity of 3 Lots of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Volunteers ≥ 15y

Phase: N/A Priority: Normal
NCT ID: NCT00696917 Org: User:
Start: 04/30/99 End: - Due: -

Evaluate Safety & Immunogenicity of a Pandemic Influenza Vaccine (GSK1562902A) in Children

Phase: N/A Priority: Normal
NCT ID: NCT00502593 Org: User:
Start: 07/23/07 End: 12/04/09 Due: 12/04/10

Ofatumumab in Japanese Patients With CD20 Positive Follicular Lymphoma or Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00742144 Org: User:
Start: 09/19/08 End: 11/18/09 Due: 11/18/10

SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fast Admin

Phase: N/A Priority: Normal
NCT ID: NCT01262989 Org: User:
Start: 01/04/10 End: 01/26/10 Due: 01/26/11

A Study to Assess Frailty of Subjects During ZOSTER-006 and ZOSTER-022

Phase: N/A Priority: Normal
NCT ID: NCT03563183 Org: User:
Start: 06/05/18 End: 04/30/19 Due: 04/30/20

Human Papillomavirus Vaccine Immunogenicity and Safety Trial in Young Adult Women With GSK Biologicals Novel HPV Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00359619 Org: User:
Start: 09/12/06 End: 01/30/07 Due: 01/30/08

A Study to Test 2 Doses of the HRV Vaccine in Healthy Infants.

Phase: N/A Priority: Normal
NCT ID: NCT00140673 Org: User:
Start: 08/05/03 End: 10/20/05 Due: 10/20/06

Seasonal Affective Depression (SAD) Study

Phase: N/A Priority: Normal
NCT ID: NCT00069459 Org: User:
Start: 09/23/03 End: 06/03/04 Due: 06/03/05

In Situ Caries Efficacy of Fluoride Toothpastes

Phase: N/A Priority: Normal
NCT ID: NCT00708097 Org: User:
Start: 04/30/08 End: 07/31/08 Due: 07/31/09

Efficacy and Safety Study of Fluticasone Proponate Inhalation Solution in Adult and Adolescent Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01687283 Org: User:
Start: 09/27/12 End: 11/07/13 Due: 11/07/14

Sensor and Electronic Health Records (EHR) Integration Pilot Study

Phase: N/A Priority: Normal
NCT ID: NCT03357341 Org: User:
Start: 07/23/18 End: 09/27/19 Due: 09/27/20

Efficacy and Safety Study of GSK679586 in Patients With Severe Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00843193 Org: User:
Start: 12/09/08 End: 07/25/10 Due: 07/25/11